Sellas Life Sciences Group Inc (SLS)
R&D Expense Growth
-16.10%
Fiscal year · Period ending:
SLS R&D Expense Growth
Latest reported-16.10%period ending
Latest reported-16.10%period ending
SLS FY R&D Growth (YoY) (0.00% → -16.10%)
Latest values, visible window
High-resolution chart · PNG
SLS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -16.0976% | |
| -20.4565% | |
| -20.6852% | |
| 41.6113% | |
| 130.2736% | |
| -8.2625% | |
| -44.7617% | |
| 201.912% | |
| -69.4512% | |
| -15.8867% | |
| -16.7278% | |
| 34.5322% | |
| 44.2179% | |
| 26.6597% | |
| 46.5515% | |
| -11.4597% | |
| 26.0561% | |
| 4.5502% | |
| 419.7997% | |
| 0% |